Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022

John Thornhill(Barts Health NHS Trust), Sapha Barkati(St George’s University Hospitals NHS Foundation Trust), Sharon Walmsley(University Health Network), Juergen Rockstroh(University Hospital Bonn), Andrea Antinori(St George’s University Hospitals NHS Foundation Trust), Luke B. Harrison(St George’s University Hospitals NHS Foundation Trust), Romain Palich(St George’s University Hospitals NHS Foundation Trust), Achyuta Nori(St George’s University Hospitals NHS Foundation Trust), Iain Reeves(St George’s University Hospitals NHS Foundation Trust), Maximillian S. Habibi(St George’s University Hospitals NHS Foundation Trust), Vanessa Apea(Barts Health NHS Trust), Christoph Boesecke(University Hospital Bonn), Linos Vandekerckhove(St George’s University Hospitals NHS Foundation Trust), Michal Yakubovsky(Tel Aviv Sourasky Medical Center), Elena Sendagorta(Hospital Universitario La Paz), José Luís Blanco(St George’s University Hospitals NHS Foundation Trust), Éric Florence(St George’s University Hospitals NHS Foundation Trust), Davide Moschese(St George’s University Hospitals NHS Foundation Trust), Fernando Maltêz(St George’s University Hospitals NHS Foundation Trust), Abraham Goorhuis(St George’s University Hospitals NHS Foundation Trust), Valérie Pourcher(St George’s University Hospitals NHS Foundation Trust), Pascal Migaud(St George’s University Hospitals NHS Foundation Trust), Sebastian Noé(St George’s University Hospitals NHS Foundation Trust), Claire Pintado(Université Paris Cité), Fabrizio Maggi(St George’s University Hospitals NHS Foundation Trust), Ann‐Brit Eg Hansen(St George’s University Hospitals NHS Foundation Trust), Christian Hoffmann(St George’s University Hospitals NHS Foundation Trust), Jezer I. Lezama(St George’s University Hospitals NHS Foundation Trust), Cristina Mussini(St George’s University Hospitals NHS Foundation Trust), AnnaMaria Cattelan(St George’s University Hospitals NHS Foundation Trust), Keletso Makofane(Harvard University), Darrell H. S. Tan(St. Michael's Hospital), Silvia Nozza(St George’s University Hospitals NHS Foundation Trust), Johannes Nemeth(St George’s University Hospitals NHS Foundation Trust), Marina B. Klein(St George’s University Hospitals NHS Foundation Trust), Chloe Orkin(Barts Health NHS Trust)
New England Journal of Medicine
July 21, 2022
Cited by 2,136Open Access
Full Text

Abstract

BACKGROUND: Before April 2022, monkeypox virus infection in humans was seldom reported outside African regions where it is endemic. Currently, cases are occurring worldwide. Transmission, risk factors, clinical presentation, and outcomes of infection are poorly defined. METHODS: We formed an international collaborative group of clinicians who contributed to an international case series to describe the presentation, clinical course, and outcomes of polymerase-chain-reaction-confirmed monkeypox virus infections. RESULTS: We report 528 infections diagnosed between April 27 and June 24, 2022, at 43 sites in 16 countries. Overall, 98% of the persons with infection were gay or bisexual men, 75% were White, and 41% had human immunodeficiency virus infection; the median age was 38 years. Transmission was suspected to have occurred through sexual activity in 95% of the persons with infection. In this case series, 95% of the persons presented with a rash (with 64% having ≤10 lesions), 73% had anogenital lesions, and 41% had mucosal lesions (with 54 having a single genital lesion). Common systemic features preceding the rash included fever (62%), lethargy (41%), myalgia (31%), and headache (27%); lymphadenopathy was also common (reported in 56%). Concomitant sexually transmitted infections were reported in 109 of 377 persons (29%) who were tested. Among the 23 persons with a clear exposure history, the median incubation period was 7 days (range, 3 to 20). Monkeypox virus DNA was detected in 29 of the 32 persons in whom seminal fluid was analyzed. Antiviral treatment was given to 5% of the persons overall, and 70 (13%) were hospitalized; the reasons for hospitalization were pain management, mostly for severe anorectal pain (21 persons); soft-tissue superinfection (18); pharyngitis limiting oral intake (5); eye lesions (2); acute kidney injury (2); myocarditis (2); and infection-control purposes (13). No deaths were reported. CONCLUSIONS: In this case series, monkeypox manifested with a variety of dermatologic and systemic clinical findings. The simultaneous identification of cases outside areas where monkeypox has traditionally been endemic highlights the need for rapid identification and diagnosis of cases to contain further community spread.


Related Papers

No related papers found

Powered by citation graph analysis